Adviser — Portfolio Company Turnaround
Switzerland·Funds & Asset Management·Consumer and industrial investments· Zurich·Posted 23 September 2026
Applications close 27 October 2026
Consumer and industrial investments organisation in Switzerland
Partner-sourced
Sourced through a partner search firm or the sponsor's own nomination committee, and verified before listing.
The problem this seat exists to solve
The adviser will help investment decision-makers evaluate turnaround needs across operating businesses without forcing dissimilar problems into one recovery playbook. The central question is which interventions are economically justified, executable and appropriately supported by ownership.
Diagnostic approach
Assess each business through its cash runway, operating constraints, management capability and realistic recovery options. Separate a financing problem from a weak competitive position or persistent execution failure. Identify where additional capital would enable a credible plan and where it would merely fund continuing losses.
Recommendations and challenge
Develop company-specific intervention priorities, then compare their funding demands and management requirements at portfolio level. Advise on the sequencing of executive support, operational improvement, refinancing or strategic alternatives. Make dependencies and uncertainties clear, particularly where several businesses compete for the same capital or specialist resources.
Use a common investment decision language while preserving each business’s distinct recovery logic. A consumer business may need assortment and channel changes; an industrial operation may need capacity, reliability or contract intervention. Compare proposed support on the basis of additional value that can realistically be preserved, the capital at risk and management’s capacity to execute. The adviser should identify where the owner’s preferred timetable conflicts with operating reality and explain whether staged funding or a narrower recovery scope would produce a more defensible outcome.
Who should apply
Relevant candidates will have worked across more than one turnaround and demonstrate judgement about when not to pursue a recovery strategy. They should understand consumer and industrial operating economics, investment governance and the practical limits of owner influence. Strong candidates can explain both a successful intervention and a case where an early change of direction reduced further value loss.
What the engagement leaves behind
Expected outputs include prioritised intervention papers, explicit funding gates and a monitoring approach tailored to each recovery thesis. The adviser supplies independent judgement; investment approvals and operating authority remain with the relevant decision-makers. Recommendations should be sufficiently transparent to challenge without requiring confidence in the adviser’s reputation alone.
Terms
- Where the board sits
- Zurich, Switzerland
- Applications close
- 27 October 2026
- Appointment
- Advisory engagement
Before you apply — an advisory engagement
No office of director, and no appointment formalities.
An advisory engagement creates no directorship in Switzerland. There is no registry filing, no regulator pre-approval, no residency arithmetic and no statutory director liability — which is why it is so often the right first step into a market you do not yet know.
- On this brief
- Independence
- Where the engagement specifies independence from any search that follows, that is a requirement of the engagement rather than a courtesy — an adviser to a board is not a candidate for it.
Also open in Switzerland
All mandates in this market →Investment Committee Member — Private Real Estate
Switzerland·Property & Real Estate
Property investment organisation in Switzerland
The committee seeks a member who can form an independent view of property investments and explain it clearly, including when the conclusion is to decline. Candidates should have substantial underwriting or investment-approval experience and a record of reviewing outcomes after capital was committed.
Board Member — Compensation Committee
Switzerland·Healthcare & Life Sciences
SIX-listed life sciences company
Members of the compensation committee are elected individually by the general meeting under CO Art. 733, and shareholders vote bindingly on aggregate compensation. The company needs a member who can defend its pay architecture to international investors annually.
Global ID Exchange
One account. Every market your record travels to.
A free account applies to one mandate a week, in any market — statutory, interim or advisory — and your dashboard reads every brief that opens in the exchanges you follow. Premium removes the weekly cap.